Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioLineRx Ltd. BLRX

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the...

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:BLRX)

Fundamentals Snapshot (NDAQ:BLRX)

Current News (NDAQ:BLRX)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

PR Newswire 1 day ago

BLRX Investors Have Opportunity to Lead BioLineRx Ltd. Securities Fraud Lawsuit

PR Newswire 4 days ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PR Newswire 4 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

Newsfile 6 days ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

Newsfile 8 days ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PR Newswire 10 days ago

BioLineRx Ltd. (BLRX) Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioLineRx Ltd.

Business Wire 10 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioLineRx Ltd. - BLRX

PR Newswire 11 days ago

BLRX Investors Have Opportunity to Lead BioLineRx Ltd. Securities Fraud Lawsuit

PR Newswire 13 days ago

Opinion & Analysis (NDAQ:BLRX)

No current opinion is available.

Bullboard Posts (NDAQ:BLRX)

RE:RE:RE:Entry here

There she goes!!!  Patience pays!!!!
mevani - July 2, 2021

RE:RE:Entry here

Patience pays!
mevani - July 1, 2021

RE:Entry here

I am adding here.   
mevani - May 5, 2021

Dang ......

can't win em all
Iseneschal - May 4, 2021

RE:Entry here

Got to be quick.......taking anything it gives me  No position
Iseneschal - May 4, 2021

Entry here

1 st position
Iseneschal - May 4, 2021